Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1993 1
1995 1
1996 1
2003 1
2005 3
2006 1
2007 1
2008 1
2009 3
2010 4
2011 9
2012 3
2013 6
2014 8
2015 9
2016 21
2017 16
2018 15
2019 15
2020 12
2021 22
2022 21
2023 19
2024 19
2025 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Results by year

Filters applied: . Clear all
Page 1
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators. Schüpke S, et al. Among authors: kufner s. N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475799 Clinical Trial.
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction.
Stähli BE, Varbella F, Linke A, Schwarz B, Felix SB, Seiffert M, Kesterke R, Nordbeck P, Witzenbichler B, Lang IM, Kessler M, Valina C, Dibra A, Rohla M, Moccetti M, Vercellino M, Gaede L, Bott-Flügel L, Jakob P, Stehli J, Candreva A, Templin C, Schindler M, Wischnewsky M, Zanda G, Quadri G, Mangner N, Toma A, Magnani G, Clemmensen P, Lüscher TF, Münzel T, Schulze PC, Laugwitz KL, Rottbauer W, Huber K, Neumann FJ, Schneider S, Weidinger F, Achenbach S, Richardt G, Kastrati A, Ford I, Maier W, Ruschitzka F; MULTISTARS AMI Investigators. Stähli BE, et al. N Engl J Med. 2023 Oct 12;389(15):1368-1379. doi: 10.1056/NEJMoa2307823. Epub 2023 Aug 27. N Engl J Med. 2023. PMID: 37634190 Clinical Trial.
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM Trial.
Desai MY, Okushi Y, Jadam S, Olivotto I, Owens A, Nissen SE, Popovic ZB, Garcia-Pavia P, Lopes RD, Elliott PM, Fernandes F, Geske JB, Maier L, Wolski K, Wang Q, Jaber W, Gong Z, Florea V, Fronheiser M, Leva A, Aronson R, Abraham T; ODYSSEY-HCM Investigators. Desai MY, et al. J Am Coll Cardiol. 2025 Dec 16;86(24):2434-2449. doi: 10.1016/j.jacc.2025.08.019. Epub 2025 Aug 27. J Am Coll Cardiol. 2025. PMID: 40864019 Clinical Trial.
Management of high-risk acute pulmonary embolism: an emulated target trial analysis.
Stadlbauer A, Verbelen T, Binzenhöfer L, Goslar T, Supady A, Spieth PM, Noc M, Verstraete A, Hoffmann S, Schomaker M, Höpler J, Kraft M, Tautz E, Hoyer D, Tongers J, Haertel F, El-Essawi A, Salem M, Rangel RH, Hullermann C, Kriz M, Schrage B, Moisés J, Sabate M, Pappalardo F, Crusius L, Mangner N, Adler C, Tichelbäcker T, Skurk C, Jung C, Kufner S, Graf T, Scherer C, Villegas Sierra L, Billig H, Majunke N, Speidl WS, Zilberszac R, Chiscano-Camón L, Uribarri A, Riera J, Roncon-Albuquerque R Jr, Terauda E, Erglis A, Tavazzi G, Zeymer U, Knorr M, Kilo J, Möbius-Winkler S, Schwinger RHG, Frank D, Borst O, Häberle H, De Roeck F, Vrints C, Schmid C, Nickenig G, Hagl C, Massberg S, Schäfer A, Westermann D, Zimmer S, Combes A, Camboni D, Thiele H, Lüsebrink E; High-risk P. E. Investigator Group. Stadlbauer A, et al. Among authors: kufner s. Intensive Care Med. 2025 Mar;51(3):490-505. doi: 10.1007/s00134-025-07805-4. Epub 2025 Feb 25. Intensive Care Med. 2025. PMID: 39998658 Free PMC article.
Ticagrelor vs Prasugrel for Acute Coronary Syndrome in Routine Care.
Krüger N, Krefting J, Kessler T, Schmieder R, Starnecker F, Dutsch A, Graesser C, Meyer-Lindemann U, Storz T, Pugach I, Frieß C, Chen Z, Bongiovanni D, Manea I, Dreischulte T, Offenborn F, Krase P, Sager HB, Wiebe J, Kufner S, Xhepa E, Joner M, Trenkwalder T, Gueldener U, Kastrati A, Cassese S, Schunkert H, von Scheidt M; DigiMed Bayern Consortium. Krüger N, et al. Among authors: kufner s. JAMA Netw Open. 2024 Dec 2;7(12):e2448389. doi: 10.1001/jamanetworkopen.2024.48389. JAMA Netw Open. 2024. PMID: 39621344 Free PMC article.
Prehospital thrombolytic treatment of high-risk acute pulmonary embolism.
Lanz H, Binzenhöfer L, Verbelen T, Stadlbauer A, Camboni D, Zimmer S, Nickenig G, Thiele H, Lüsebrink E; High-risk Investigator Group. Lanz H, et al. Crit Care. 2025 Jul 7;29(1):284. doi: 10.1186/s13054-025-05465-w. Crit Care. 2025. PMID: 40624546 Free PMC article. No abstract available.
Diabetes mellitus and femoropopliteal in-stent restenosis.
Voll F, Wolf F, Ingwersen M, Kinstner CM, Kufner S, Ibrahim T, Ott I, Krankenberg H, Fusaro M, Cassese S. Voll F, et al. Among authors: kufner s. Vasa. 2022 Jul;51(4):247-255. doi: 10.1024/0301-1526/a001006. Epub 2022 May 11. Vasa. 2022. PMID: 35543439
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
Giacoppo D, Alvarez-Covarrubias HA, Koch T, Cassese S, Xhepa E, Kessler T, Wiebe J, Joner M, Hochholzer W, Laugwitz KL, Schunkert H, Kastrati A, Kufner S. Giacoppo D, et al. Among authors: kufner s. Eur Heart J. 2023 Apr 17;44(15):1343-1357. doi: 10.1093/eurheartj/ehad026. Eur Heart J. 2023. PMID: 36807512 Clinical Trial.
202 results